arrow
R

Rafet Başar

The University of Texas MD Anderson Cancer Center
H指数:30
被引数:8,384

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Depletion of an immature cord blood NK subset reverses trogocytosis-driven CAR NK dysfunction

耗竭一种不成熟脐带血NK亚群可逆转吞噬细胞溶解作用驱动的CAR NK功能障碍

2026-07-290
OAAI
Role of BK Virus CTLs in the Treatment of BK Virus–Associated Nephropathy in Kidney-Transplant and Hematopoietic Cell Transplant Recipients

BK病毒细胞毒性T淋巴细胞在治疗肾移植和造血细胞移植受者BK病毒相关肾病中的作用

2026-02-050
PREAI
Ex Vivo Mesenchymal Progenitor Cell-based Cord Blood Cell Expansion and Exofucosylation to Enhance Transplant Engraftment

离体间充质祖细胞介导的脐带血细胞扩增及外岩藻糖基化,以增强移植植入效果

2025-11-190
PRE
Genome-wide CRISPR screens identify critical targets to enhance CAR-NK cell antitumor potency

全基因组CRISPR筛选鉴定出增强CAR-NK细胞抗肿瘤效力的关键靶点

2025-08-210
OAAI
Author Correction: Allogeneic NK cells with a bispecific innate cell engager in refractory relapsed lymphoma: a phase 1 trial

作者更正: 同种异体NK细胞与双特异性先天细胞衔接器治疗难治性复发性淋巴瘤: 1期试验

2025-06-260
PRE
Overcoming CD226-related immune evasion in acute myeloid leukemia with CD38 CAR-engineered NK cells

通过CD38 CAR工程化NK细胞克服急性髓系白血病中CD226相关的免疫逃逸

2025-01-010
OA
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML
2024-09-110
PRE
CD28 Costimulation Augments CAR Signaling in NK Cells via the LCK/CD3ζ/ZAP70 Signaling Axis
2024-07-223
PRE
A cryopreserved allogeneic anti-BCMA CAR-NK cellular therapy exhibits both innate and CAR-mediated MM cell killing in vitro and in vivo
2024-03-220
PRE
Increased expression of CD70 in relapsed acute myeloid leukemia after hypomethylating agents
2024-02-223
OAAI
Ex Vivo Expanded Cord Blood Natural Killer Cells Combined with Rituximab and High-Dose Chemotherapy and Autologous Stem Cell Transplantation for B Cell Non-Hodgkin Lymphoma

体外扩增脐血自然杀伤细胞联合利妥昔单抗及大剂量化疗和自体干细胞移植治疗b细胞非霍奇金淋巴瘤

2024-02-014
OAAI
KIR-based inhibitory CARs overcome CAR-NK cell trogocytosis-mediated fratricide and tumor escape (vol 28, pg 2133, 2022)
2024-01-050
OA
Loss of metabolic fitness drives tumor resistance after CAR-NK cell therapy and can be overcome by cytokine engineering
2023-07-2838
OAAI
Anti-miR-93-5p therapy prolongs sepsis survival by restoring the peripheral immune response
2023-07-179
OAAI
Activated B cells suppress T-cell function through metabolic competition

活化的b细胞通过代谢竞争抑制T细胞功能

2022-12-218
OAAI